Royalty Pharma Plc (RPRX) Stock Institutional Trading Activity


Royalty Pharma Plc (RPRX) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q3 2025), investors with some of the largest reported share count changes include Dorsey Asset Management, Torray Fund, Sequoia Financial Advisors, Viking Global Investors, and Renaissance Technologies LLC. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q3 2025Torray FundBuy14,107702,883$24,797,712
Q3 2025Sequoia Financial AdvisorsBuy3,3609,830$346,815
Q3 2025Dorsey Asset ManagementBuy2,350,4492,350,449$82,923,841
Q2 2025Torray FundSell-173,242688,776$24,816,599
Q2 2025Sequoia Financial AdvisorsBuy6,4706,470$233,119
Q2 2025Viking Global InvestorsSell-7,966,4792,597,460$93,586,484
Q1 2025Torray FundBuy178,011862,018$26,834,620
Q1 2025Viking Global InvestorsSell-1,643,94610,563,939$328,855,421
Q4 2024Torray FundSell-173,912684,007$17,449,019
Q4 2024Viking Global InvestorsBuy113,86412,207,885$311,423,146
Q3 2024Torray FundBuy164,361857,919$24,270,529
Q3 2024Viking Global InvestorsBuy123,96312,094,021$342,139,854
Q2 2024Torray FundBuy686,181693,558$18,289,124
Q2 2024Viking Global InvestorsBuy484,51111,970,058$315,650,429
Q1 2024Torray FundSell-498,3637,377$20,349,722
Q1 2024Renaissance Technologies LLCSell-473,01010,190$309
Q1 2024Viking Global InvestorsBuy1,398,13011,485,547$348,816,062
Q4 2023Torray FundBuy93,107505,740$14,206,237
Q4 2023Viking Global InvestorsBuy623,21610,087,417$283,355,544
Q3 2023Torray FundSell-1,182412,633$11,198,860
Q3 2023Renaissance Technologies LLCSell-287,500483,200$13,114
Q3 2023Viking Global InvestorsSell-386,7319,464,201$256,858,415
Q2 2023Torray FundBuy276,643413,815$12,720,673
Q2 2023Renaissance Technologies LLCSell-530,200770,700$23,691
Q2 2023Viking Global InvestorsSell-1,353,3179,850,932$302,817,650
Q1 2023Torray FundSell-199137,172$4,942,307
Q1 2023Renaissance Technologies LLCBuy431,9001,300,900$46,871
Q1 2023Viking Global InvestorsBuy1,195,73811,204,249$403,689,091
Q4 2022Torray FundSell-1,653137,371$5,428,902
Q4 2022Renaissance Technologies LLCBuy685,100869,000$34,343

Frequently asked questions about RPRX activity

  • Which institutional owners are buying RPRX?

    Institutional owners buying RPRX include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in RPRX activity?

    "Buy" means an investor increased their reported position in RPRX compared to the prior reporting period. This reflects growing exposure to Royalty Pharma Plc (RPRX) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in RPRX increasing?

    Institutional interest in RPRX can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.